CDKN2A copy number alteration in bladder cancer: integrative analysis in patient-derived xenografts and cancer patients

MA Papadimitriou, KM Pilala, K Panoutsopoulou… - Molecular Therapy …, 2024 - cell.com
revealed CDKN2A copy-number loss as the most frequent alteration of bladder tumors, …
presents the REMARK diagram of our clinical study, while detailed clinicopathological 153 …

[HTML][HTML] … analysis of differentially mutated genes in non-muscle and muscle-invasive bladder cancer in the Chinese population by whole exome sequencing

F Wang, X Dong, F Yang, N Xing - Frontiers in Genetics, 2022 - frontiersin.org
… Our analysis revealed that several genes in NMIBC did not … The clinicopathological
characteristics of enrolled patients were … As for the comparison of somatic mutations between male …

[HTML][HTML] CDKN1A/p21WAF1, RB1, ARID1A, FLG, and HRNR mutation patterns provide insights into urinary tract environmental exposure carcinogenesis and potential …

TE Arnoff, WS El-Deiry - American Journal of Cancer Research, 2021 - ncbi.nlm.nih.gov
… vulnerabilities in bladder tumors with CDKN1A mutations, we … mutations are the most
common somatic lesion in bladderreveal a high prevalence of inactivating truncating mutations

Low-coverage sequencing of urine sediment DNA for detection of copy number aberrations in bladder cancer

Y Cai, X Yang, S Lin, Y Xu, S Zhu, D Fan… - Cancer Management …, 2021 - Taylor & Francis
Clinicopathologic Characteristics of the Samples … All genomic regions that are overrepresented
(indicative of somatic … In this study, the low-coverage whole-genome sequencing method …

Genomic characterization of urologic malignancies and the relevance of clonal hematopoiesis in liquid biopsies

JVW Bacon - 2023 - open.library.ubc.ca
… to distinguish from tumour mutations. Closer investigation … Chapter 3: Identification of
somatic features of response and … -invasive bladder tumours have undergone a whole genome

Differential effects of clinically relevant N-versus C-terminal truncating CDKN1A mutations on cisplatin sensitivity in bladder cancer

RK Sikder, M Ellithi, RN Uzzo, DJ Weader… - Molecular Cancer …, 2021 - AACR
Somatic mutations that affect cellular pathways pertinent to … derived CDKN1A mutations in
bladder cancer cell lines, we targeted three CRISPR sgRNAs along the length of the CDKN1A

[HTML][HTML] Molecular Basis of Tumorigenesis of Bladder Cancer and Emerging Concepts in Developing Therapeutic Targets

RM Abdeltwab, E Yacoub, AH Rashad… - Bladder …, 2023 - content.iospress.com
Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and
clinicopathological associations with mutation burden. Nat Commun. (2014) ;5: . …

Advances in bladder cancer biology and therapy

L Tran, JF Xiao, N Agarwal, JE Duex… - … Reviews Cancer, 2021 - nature.com
… In line with the clinicopathological feature, NPS3 patients … cells but nearly undetectable in
most somatic cells due primarily to … , CDKN2B, RB1 and CDKN1A are commonly inactivated by …

High Frequency Mutant Genes in Urothelial Carcinoma Based On Genomic Landscape

H Hao, Y Zhang, Y Zheng, X Yan, X Yang - 2021 - researchsquare.com
Sequencing methods include whole genome sequencing, … upper urinary tract urothelial
carcinoma and bladder cancer. … [32] established a clinicopathological classi er of KNN51 …

[HTML][HTML] Amplification of 7p12 is associated with pathologic nonresponse to neoadjuvant chemotherapy in muscle-invasive bladder cancer

R Pichler, AK Lindner, E Compérat, P Obrist… - The American Journal of …, 2020 - Elsevier
… specimens to identify nonsynonymous mutations/exome. The … Cancer Genome Atlas cohort,
analysis of focal somatic copy number alterations by SNP-array and low pass whole genome